Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Nitroglycerin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nitroglycerin and what is the scope of nitroglycerin patent protection?

is the generic ingredient in sixteen branded drugs marketed by Abraxis Pharm, Pohl Boskamp, Kremers Urban Pharms, Sanofi Aventis Us, Intl Medication, Hospira, Smith And Nephew, Luitpold, Pfizer Pharms, Novartis, Merck Sharp Dohme, Fougera Pharms Inc, Mylan Technologies, Forest Labs Inc, Parke Davis, Baxter Hlthcare, Valeant Pharms, Valeant Pharms North, Medicis, Rorer, Mist Pharms Llc, Hercon Pharm, Dr Reddys Labs Inc, and Perrigo Israel, and is included in forty-two NDAs. There are four patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Nitroglycerin has twenty-nine patent family members in sixteen countries.

There are thirty-six drug master file entries for nitroglycerin. Thirty-nine suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: nitroglycerin

Drug Master File Entries: see list36
Suppliers / Packagers: see list39
Bulk Api Vendors: see list16
Clinical Trials: see list42
Patent Applications: see list4,086
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nitroglycerin at DailyMed

Pharmacology for Ingredient: nitroglycerin

Drug ClassNitrate Vasodilator
Physiological EffectVasodilation

Tentative approvals for NITROGLYCERIN

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe0.2MG/HRFilm, Extended Release; Transdermal
► Subscribe► Subscribe0.4MG/HRFilm, Extended Release; Transdermal
► Subscribe► Subscribe0.6MG/HRFilm, Extended Release; Transdermal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
INJECTABLE;INJECTION018774-001Jan 19, 1983DISCNNoNo► Subscribe► Subscribe
Pohl Boskamp
INJECTABLE;INJECTION018672-002Aug 30, 1983DISCNNoNo► Subscribe► Subscribe
FILM, EXTENDED RELEASE;TRANSDERMAL089773-001Aug 30, 1996AB1RXNoNo► Subscribe► Subscribe
Parke Davis
INJECTABLE;INJECTION018588-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
INJECTABLE;INJECTION072034-001May 24, 1988RXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus